LMTK3 and breast cancer: Based on previous observations associating LMTK3 with tamoxifen resistance in breast cancer [1, 12], we set out to investigate a possible role of LMTK3 in breast cancer cells’ response to cytotoxic treatment in vitro and in vivo.